SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-19-015354
Filing Date
2019-03-21
Accepted
2019-03-21 16:06:21
Documents
7
Period of Report
2019-03-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A tv516866_pre14a.htm PRE 14A 142516
2 GRAPHIC tv516866_img1.jpg GRAPHIC 25770
3 GRAPHIC tv516866_img2.jpg GRAPHIC 5906
4 GRAPHIC tv516866_img3.jpg GRAPHIC 21337
5 GRAPHIC tv516866_img4.jpg GRAPHIC 4614
6 GRAPHIC tv516866_img5.jpg GRAPHIC 172686
7 GRAPHIC tv516866_img6.jpg GRAPHIC 184115
  Complete submission text file 0001144204-19-015354.txt   715086
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-26770 | Film No.: 19697088
SIC: 2836 Biological Products, (No Diagnostic Substances)